Ignite Creation Date:
2024-05-06 @ 7:30 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06037733
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-09-07
Brief Title:
Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy
Sponsor:
Hubei Cancer Hospital
Organization:
Hubei Cancer Hospital
Organization Data
Organization:
Hubei Cancer Hospital
Class:
OTHER
Study ID:
OMCTV-HC-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hubei Cancer Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
HAN GUANG
Responsible Party Title:
Director of the department of Radiotherapy Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hubei Cancer Hospital
Old Name:
None
Old Organization:
None